StonvexLoading…
StonvexStonvexStonvexCore line items from BGC's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $2.44B | $1.81B | $1.61B | $1.41B |
Operating Income | $213.75M | $173.14M | $57.71M | $97.45M |
Net Income | $154.96M | $123.23M | $38.77M | $58.87M |
EPS (Diluted) | $0.31 | $0.25 | $0.07 | $0.13 |
Total Assets | $4.41B | $3.59B | $3.18B | $3.07B |
Total Liabilities | $3.27B | $2.51B | $2.28B | $2.33B |
Cash & Equivalents | $851.50M | $711.58M | $655.64M | $484.99M |
Free Cash Flow OCF − CapEx | $372.87M | $285.73M | $390.28M | $213.77M |
Shares Outstanding | 480.95M | 479.14M | 489.99M | 499.41M |